Published in Am J Hematol on February 24, 2012
Healthcare burden of venous thromboembolism in childhood chronic renal diseases. Pediatr Nephrol (2014) 0.79
Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol (2013) 0.78
Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population. Cardiol Ther (2016) 0.77
The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol (2015) 0.77
Development of a pediatric-specific clinical probability tool for diagnosis of venous thromboembolism: a feasibility study. Pediatr Res (2014) 0.76
Complications and 30-day Outcomes Associated With Venous Thromboembolism in the Pediatric Orthopaedic Surgical Population. J Am Acad Orthop Surg (2016) 0.75
Venous thromboembolism in children and adolescents. Blood Res (2016) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost (2005) 4.64
Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.31
Propensity scores in cardiovascular research. Circulation (2007) 2.96
Development of the human coagulation system in the full-term infant. Blood (1987) 2.69
Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med (2004) 2.60
Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics (2009) 2.35
Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics (1995) 2.14
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood (1994) 2.14
In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes. Blood (2010) 1.93
Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. Blood (2011) 1.83
Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood (2001) 1.75
Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr (2009) 1.72
Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr (2001) 1.68
Low-molecular-weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol (2000) 1.62
Mortality-adjusted duration of mechanical ventilation in critically ill children with symptomatic central venous line-related deep venous thrombosis. Crit Care Med (2011) 1.61
Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interv Radiol (2011) 1.51
Varied opinions on thrombolysis for venous thromboembolism in infants and children: findings from a survey of pediatric hematology-oncology specialists. Pediatr Blood Cancer (2009) 1.50
Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor. J Med Chem (2005) 1.40
Determination of risk factors for deep venous thrombosis in hospitalized children. J Pediatr Surg (2008) 1.37
A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood (2007) 1.32
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation (2008) 1.26
Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases. Arterioscler Thromb Vasc Biol (2007) 1.25
Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases. Pediatr Blood Cancer (2011) 1.24
Venous thrombosis in children. J Thromb Haemost (2003) 1.24
Propensity scores: help or hype? Nephrol Dial Transplant (2004) 1.23
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children. Blood (2011) 1.22
An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res (2003) 1.20
How I treat venous thrombosis in children. Blood (2005) 1.17
Thrombosis and cancer. Hum Pathol (1987) 1.17
Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J Clin Oncol (2006) 1.15
Thrombotic complications of central venous catheters in children. Curr Opin Hematol (2003) 1.12
The effects of heparin and low molecular weight heparins on bone. Thromb Res (2007) 1.11
Bivalirudin. Thromb Haemost (2008) 1.11
A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res (2003) 1.06
Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood (1993) 1.06
Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis. J Thromb Haemost (2007) 1.04
Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg (2003) 1.02
Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. J Thromb Haemost (2011) 1.00
Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol (2011) 0.98
Facts and artefacts of coagulation assays for factor Xa inhibitors. Thromb Haemost (2010) 0.97
Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro. Br J Surg (2005) 0.96
Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia. J Thromb Haemost (2008) 0.96
Health care expenditures associated with venous thromboembolism among children. Thromb Res (2011) 0.96
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia. Am J Hematol (2010) 0.95
Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost (1997) 0.95
Dosing and monitoring of enoxaparin (Low molecular weight heparin) therapy in children. Br J Haematol (2010) 0.95
Old and new anticoagulant drugs: a minireview. Ann Med (2011) 0.94
How I treat postthrombotic syndrome. Blood (2009) 0.93
Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg (2002) 0.93
FondaKIDS: a prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age. Pediatr Blood Cancer (2011) 0.93
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood (1995) 0.92
Antiphospholipid syndrome. Pediatr Clin North Am (2005) 0.92
Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study. Pediatr Blood Cancer (2010) 0.92
Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost (2004) 0.91
Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts. Calcif Tissue Int (2003) 0.90
Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol (2007) 0.90
Difficulties in performing clinical trials of antithrombotic therapy in neonates and children. Thromb Res (2005) 0.89
Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system. Thromb Haemost (2011) 0.89
Pediatric catheterization laboratory anticoagulation with bivalirudin. Catheter Cardiovasc Interv (2011) 0.88
Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr (2011) 0.88
Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events. Thromb Haemost (2005) 0.88
Paradoxical embolism in a preterm infant. Dev Med Child Neurol (2004) 0.88
Reduced bone density in children on long-term warfarin. Pediatr Res (2005) 0.88
Pharmacokinetic and pharmacodynamic basis for effective argatroban dosing in pediatrics. J Clin Pharmacol (2010) 0.87
The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemp Clin Trials (2009) 0.85
Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res (1994) 0.85
Venous thromboembolism and adolescent and young adult oncology inpatients in US children's hospitals, 2001 to 2008. J Pediatr (2011) 0.85
Testing children for inherited thrombophilia: more questions than answers. Br J Haematol (2009) 0.84
Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models. Eur J Pharmacol (2005) 0.83
Heparin therapy in pediatric patients. Semin Thromb Hemost (1997) 0.83
Heparin-induced thrombocytopenia in children. J Paediatr Child Health (2003) 0.83
The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur J Pediatr (1999) 0.83
Thrombophilic conditions in the adolescent: the gynecologic impact. Obstet Gynecol Clin North Am (2009) 0.81
Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis. Thromb Haemost (1992) 0.81
Venous thrombosis in children. Expert Rev Cardiovasc Ther (2008) 0.79
Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study. J Thromb Haemost (2007) 0.79
Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics (2002) 0.78
Decision analysis in pediatric hematology. Pediatr Clin North Am (2008) 0.78
Pulmonary thromboendarterectomy in adolescents and young adults. Pediatr Pulmonol (2010) 0.77
Post-thrombotic syndrome is uncommon in childhood cancer survivors. J Pediatr (2006) 0.77
Fondaparinux sodium: a selective inhibitor of factor Xa. Am J Health Syst Pharm (2001) 0.77
The use of elastic compression stockings for post-thrombotic syndrome in a child. Pediatr Blood Cancer (2009) 0.77
Low-molecular-weight heparin-induced thrombocytopenia in a child. Ann Pharmacother (2003) 0.77
Lupus anticoagulants in children. Curr Opin Hematol (2003) 0.76
Secondary data demonstrate safety of splenectomy in spherocytosis. Pediatr Blood Cancer (2009) 0.76
Warfarin treatment outcomes in children monitored at home with a point-of-care device. Thromb Haemost (2011) 0.76
The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it? J Thromb Thrombolysis (2006) 0.76
Chronic thromboembolic pulmonary hypertension in pediatric patients. J Thorac Cardiovasc Surg (2010) 0.76